As severe CFTR genotype increases the risk of diabetes independently of pancreatic exocrine dysfunction [30], a screening for prediabetes is mandatory in patients with two severe CFTR mutations, particularly F508del, and insulin supplementation seems a rational therapy to consider [90,91]. This evidence concerns the gene INS and diabetes mellitus.